Hopital Augustin Morvan; Federation De Cancerologie
Brest, France
Hospital in Brest
2 Av. Foch, 29200 Brest
About Hopital Augustin Morvan; Federation De Cancerologie
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
ERYtech Pharma
2
Gilead Sciences
2
Clinical Trials at Hopital Augustin Morvan; Federation De Cancerologie
During the past decade, Hopital Augustin Morvan; Federation De Cancerologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on
average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma
An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer
2015-01-14
2016-11-10
Completed
510
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Augustin Morvan; Federation De Cancerologie"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Hopital Augustin Morvan; Federation De Cancerologie
According to Clinical.Site data, the most researched conditions in "Hopital Augustin Morvan; Federation De Cancerologie" are
"Breast Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Hopital Augustin Morvan; Federation De Cancerologie" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Augustin Morvan; Federation De Cancerologie
Most popular intervention types in "Hopital Augustin Morvan; Federation De Cancerologie" are "Drug" (11 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Gemcitabine" (3 trials), "Paclitaxel" (3 trials), "Trastuzumab" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Augustin Morvan; Federation De Cancerologie
The vast majority of trials in "Hopital Augustin Morvan; Federation De Cancerologie" are
11 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Hopital Augustin Morvan; Federation De Cancerologie
Currently, there are NaN active trials in "Hopital Augustin Morvan; Federation De Cancerologie".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Hopital Augustin Morvan; Federation De Cancerologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Augustin Morvan; Federation De Cancerologie, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".